Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201109172 Principal Investigator: Vij, Ravi
Title: Phase 1b/2, Multicenter, Open-label Study of the Safety and Activity of ONX 0912 in Patients with Hematological Malignancies
Phase: I/II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the safety of an investigational new drug called ONX 0912 at different dose levels and to find out what effects it has on patients and their cancer.
 
More Information:
CT.gov link
Internal Protocol Documents (requires Siteman administrative database password)